These inflammatory cells likely contribute to the pathology of obesity-induced lymphatic dysfunction since inhibition of inflammatory reactions with topical IL-2 inhibitors or genetic deficiency of CD4+ T cells decreased the severity of lymphatic injury in obese animals [59]. The gene discussed is IL2; the disease is obesity due to melanocortin 4 receptor deficiency.